2019 FINANCIAL COMMUNICATION CALENDAR
Paris, January 8, 2019 – 5.45 pm
Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), leading French group in the field of specialty in vitro medical diagnostics, announces its financial communication calendar for the next year:
- 2018 Turnover: January 29, 2019
- 2018 Annual results: April 16, 2019
- Annual Shareholders meeting: June 25, 2019
- 2019 Half-year turnover: July 23, 2019
- 2019 Half-year results: October 15, 2019
Calendar may be subject to change and is communicated on an indicative basis.
Upcoming financial meeting
2018 Turnover: January 29, 2019
| About Eurobio Scientific Eurobio Scientific (ex Diaxonhit) is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The Group has approximately 120 employees and two production units based in the Paris region and in the United States. For more information, please visit: www.eurobio-scientific.com The company is publicly listed on the Euronext Growth market in Paris Euronext Growth BPI Innovation, PEA-PME 150 and Next Biotech indices. Symbol : ALERS - ISIN Code: FR0013240934 - Reuters : ALERS.PA - Bloomberg : ALERS:FP |
| Contacts |
| Eurobio Scientific Group Denis Fortier, General Manager Hervé Duchesne de Lamotte, General Manager Tel. +33 1 69 79 64 80 | Calyptus Sophie Levesque / Mathieu Calleux Investor Relations Tel. +33 1 53 65 68 68 - eurobio-scientific@calyptus.net |
Attachment
